Dermatology
From the Journals
AAP infantile hemangioma guideline should empower primary care clinicians
Four weeks is recommended as the ideal time for IH professional consultation.
Pediatric Dermatology Consult
A 7-year-old male with a history of Crohn's disease presents with 6 months of asymptomatic, bumpy lesions on the torso and extremities.
Daily News Podcast
Deep sleep decreases, Alzheimer’s increases
There is reassuring data on pregnancy outcomes for women with atopic dermatitis.
From the Journals
Atopic dermatitis associated with increased suicidality
The disease is associated with high levels of proinflammatory cytokines, which have been isolated in the cerebrospinal fluid of patients who have...
Conference Coverage
New worldwide atopic dermatitis survey brings big surprises
PARIS – Findings of the huge 18-nation survey triggers reconsideration of adult atopic dermatitis.
Pediatric Dermatology Consult
A 6-year-old, otherwise-healthy male is brought into clinic for evaluation of papules on his neck. The rash has been present since 1 year of age and has been growing in size proportionately.
From the Journals
Gestational, umbilical cord vitamin D levels don’t predict atopic disease in offspring
Vitamin D levels measured in maternal sera during gestation and in umbilical cord blood were not predictive of the prevalence of eczema, food...
From the Journals
Anthralin shows promise as second-line agent for pediatric alopecia areata
At least 50% regrowth of scalp hair was achieved in 68% of patients treated with topical anthralin.
Pediatric Dermatology Consult
A 4-year-old boy is brought to our pediatric dermatology clinic by his mother with the concern of difficult to treat toenail fungus.
From the Journals
Review of pediatric data indicates link between vitamin D levels and atopic dermatitis severity
Data on vitamin D supplementation and AD severity “suggested potential benefit but were conflicting.”
Conference Coverage
New pediatric therapies show promise for influenza, multidrug-resistant pathogens
ORLANDO – Baloxavir, a recently approved fast-acting single-dose medication for influenza, is currently under study...